BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9033415)

  • 21. Pharmaceutical promotion.
    Harvey K
    Med J Aust; 1990 Jan; 152(2):57-8. PubMed ID: 2296230
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
    Stewart KA; Neumann PJ
    Value Health; 2002; 5(5):390-7. PubMed ID: 12201856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No more pens: what the 2009 Pharmaceutical Research and Manufacturer's Association code changes really mean.
    Meffert JJ
    Clin Dermatol; 2009; 27(4):346-9. PubMed ID: 19539160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of FDA warning letters and notices of violation issued for patient-reported outcomes promotional claims between 2006 and 2012.
    Symonds T; Hackford C; Abraham L
    Value Health; 2014 Jun; 17(4):433-7. PubMed ID: 24969004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
    Francer J; Izquierdo JZ; Music T; Narsai K; Nikidis C; Simmonds H; Woods P
    Philos Ethics Humanit Med; 2014 Mar; 9():7. PubMed ID: 24679064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. US drug industry's guidelines on advertising too limited, say critics.
    Burton B
    BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis.
    Eisenkraft Klein D; Lexchin J; Sud A; Bavli I
    PLoS One; 2023; 18(6):e0287861. PubMed ID: 37384735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breach of code on the promotion of medicines.
    Vet Rec; 2015 Jul; 177(4):85. PubMed ID: 26206961
    [No Abstract]   [Full Text] [Related]  

  • 32. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug advertising.
    Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceutical advertising: from prospectus to marketing.
    Cambronero-Saiz B
    J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
    [No Abstract]   [Full Text] [Related]  

  • 36. PMAC code of marketing practices.
    Lexchin J
    CMAJ; 1999 Jun; 160(11):1556. PubMed ID: 10447368
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethics in pharmaceutical advertising.
    Lober CW
    Dermatol Clin; 1993 Apr; 11(2):285-8. PubMed ID: 8477540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New DTC guidelines please drug companies, anger critics.
    Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
    [No Abstract]   [Full Text] [Related]  

  • 40. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
    Kata M; Sánta Z
    Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.